Skip to main content
Premium Trial:

Request an Annual Quote

Elixir Pharma and NHGRI Collaborate on Aging Gene Studies

NEW YORK, April 25 -- Elixir Pharmaceuticals said today it is collaborating on genome-wide studies of the Lamin A gene and the aging process with researchers at the National Human Genome Research Institute and the University of Michigan.

 

The Cambridge, Mass., company's announcement follows last week's announcement by the NHGRI that an associaton had been discovered between the LMNA gene and Hutchinson-Gilford progeria syndrome, a disorder that causes the most dramatic form of premature aging.

 

In the study, researchers at Francis Collins's laboratory at NHGRI and Michael Boehnke's laboratory at the University of Michigan will compare NHGRI's collection of SNPs in or around the LMNA gene with DNA samples from Elixir's collection of centenarian genomes, and look for associations between the SNPs and longevity.

 

"We expect this program will provide new insights into our overall understanding of the pathways that regulate aging, eventually leading to a new class of pharmaceutical products that can improve the health of our aging population," said Bard Geesaman, Elixir's vice president of medical development, in a statement.

 

Elixir is also working with Boston University School of Medicine researchers on a study of the genetics of human longevity.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.